Blood conservation in cardiac surgery.
Cardiac surgery is one of the largest users of blood and blood products--currently estimated at 15% of U.K. blood stocks. While the blood supply could be considered to be the safest it has ever been, there are well recognised risks associated with the transfusion of red cells and blood products. It is appropriate that attempts should be made to decrease and optimise the transfusion of blood and blood products.
Department of Anaesthetics, Golden Jubilee National Hospital, Beardrnore Street, Clydebank, G81 4HX. lynne.anderson@gjnh.scot.nhs.uk
Lynne
L
Anderson
D000465:Algorithms; D007611:Aprotinin / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control* / Q000706:statistics & numerical data; D001802:Blood Substitutes / Q000627:therapeutic use; D001803:Blood Transfusion / Q000379:methods; D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000451:nursing / Q000706:statistics & numerical data; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D015942:Factor VIIa / Q000627:therapeutic use; D006438:Hemodilution; D006489:Hemostatic Techniques; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D057725:Operative Blood Salvage; D019990:Perioperative Care / Q000379:methods / Q000451:nursing; D011175:Positive-Pressure Respiration; D011994:Recombinant Proteins / Q000627:therapeutic use; D014148:Tranexamic Acid / Q000627:therapeutic use; D065227:Transfusion Reaction; D006113:United Kingdom
D001802:Blood Substitutes; D006490:Hemostatics; D011994:Recombinant Proteins; D014148:Tranexamic Acid; D007611:Aprotinin; C103587:recombinant FVIIa; D015942:Factor VIIa; D003894:Deamino Arginine Vasopressin